Literature DB >> 6224308

Right ventricular hypertrophy in a group of coalworkers.

J M Fernie, A N Douglas, D Lamb, V A Ruckley.   

Abstract

The prevalence of right ventricular hypertrophy was studied in necropsy material from 215 coalworkers, a group which consisted of 115 men with simple or no pneumoconiosis and 100 with progressive massive fibrosis. Right ventricular hypertrophy was considered to be present if the ratio of the weight of the left ventricle plus septum to that of the right ventricle was less than 2:1. The prevalence of right ventricular hypertrophy was low (15%) in the absence of progressive massive fibrosis and appeared to be related to emphysema or airways disease or both, and not to simple pneumoconiosis. It was evident only in subjects who had smoked. In subjects with progressive massive fibrosis the prevalence of right ventricular hypertrophy was higher (34%) and it was occasionally seen in non-smokers. The prevalence increased with increasing size of lesion, and for any given size of lesion subjects with right ventricular hypertrophy had more panacinar emphysema than those without right ventricular hypertrophy. There was no relationship, however, between the extent of massive lesions or amount and type of emphysema and the degree of right ventricular hypertrophy.

Entities:  

Mesh:

Year:  1983        PMID: 6224308      PMCID: PMC459580          DOI: 10.1136/thx.38.6.436

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  20 in total

1.  [Right ventricular hypertrophy, verified by autopsy, and symptoms of its development in patients with silicosis and coal worker's pneumoconiosis (author's transl)].

Authors:  U Smidt; F Schnellbächer
Journal:  Prax Klin Pneumol       Date:  1978-06

2.  Chronic cor pulmonale. Its pathogenesis in Appalachian bituminous coal workers.

Authors:  R L Naeye; W A Laqueur
Journal:  Arch Pathol       Date:  1970-12

3.  The relation between the weight of the right ventricle and the percentage of abnormal air space in the lung in emphysema.

Authors:  P Hicken; D Heath; D Brewer
Journal:  J Pathol Bacteriol       Date:  1966-10

4.  Right ventricular hypertrophy in emphysema.

Authors:  P S Hasleton
Journal:  J Pathol       Date:  1973-05       Impact factor: 7.996

5.  Myocardial dimensions and proportions in pulmonary emphysema.

Authors:  A G Foraker; C W Bedrossian; A E Anderson
Journal:  Arch Pathol       Date:  1970-10

6.  Quantitative study of parenchyma and small conductive airways in chronic nonspecific lung disease. Use of histologic stereology and bronchial casts.

Authors:  A Depierre; J Bignon; A Lebeau; G Brouet
Journal:  Chest       Date:  1972-12       Impact factor: 9.410

7.  A prospective clinical-pathologic study of the lungs and heart in chronic obstructive lung disease.

Authors:  J H Cullen; J T Kaemmerlen; A Daoud; H L Katz
Journal:  Am Rev Respir Dis       Date:  1970-08

8.  A quantitative study of bronchial mucous gland volume, emphysema and smoking in a necropsy population.

Authors:  R C Ryder; M S Dunnill; J A Anderson
Journal:  J Pathol       Date:  1971-05       Impact factor: 7.996

9.  The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago.

Authors:  B Burrows; C M Fletcher; B E Heard; N L Jones; J S Wootliff
Journal:  Lancet       Date:  1966-04-16       Impact factor: 79.321

10.  A PATHOLOGICAL study of the lungs and heart in fatal and non-fatal chronic airways obstruction.

Authors:  K W Scott
Journal:  Thorax       Date:  1976-02       Impact factor: 9.139

View more
  2 in total

1.  Update on lung disease in coal miners.

Authors:  W K Morgan
Journal:  Br J Ind Med       Date:  1987-10

2.  Effects of nicotine on cardiovascular remodeling in a mouse model of systemic hypertension.

Authors:  E Sage Colombo; Joshua Davis; Mehran Makvandi; Mario Aragon; Selita N Lucas; Michael L Paffett; Matthew J Campen
Journal:  Cardiovasc Toxicol       Date:  2013-12       Impact factor: 3.231

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.